Patents by Inventor Bethany Moore

Bethany Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Serum protein biomarker panel for idiopathic pulmonary fibrosis
    Patent number: 12618855
    Abstract: The instant disclosure relates to methods for assessing pulmonary fibrosis disorder disease status in an individual in need thereof. One aspect of the disclosed methods may comprise: detecting a level of one or more biomarkers in a biological sample obtained from an individual, comparing the level of the one or more biomarkers to that of a control value corresponding to the one or more biomarkers, characterizing the disease status in the individual based on the level of the one or more biomarkers as compared to that of a relevant control value; and administering a treatment to said individual based on the assessment of the one or more biomarker levels.
    Type: Grant
    Filed: October 8, 2020
    Date of Patent: May 5, 2026
    Assignees: Children's Hospital Medical Center, University of Michigan
    Inventors: William D. Hardie, Assem Ziady, Bethany Moore
  • TWO COMBINED MUTATIONS THAT INTRODUCE THE SECOND ENTRY PATHWAY TO SYNTHESIZED LIGNIN FROM TYROSINE IN PLANTS
    Publication number: 20240318160
    Abstract: The present invention provides engineered phenylalanine ammonia-lyase (PAL) enzymes comprising one or more mutations that increase the enzymes' tyrosine ammonia-lyase (TAL) activity. Also provided are plants comprising the engineered PAL enzymes and methods of using these plants to sequester CO2 or produce phenylpropanoid-derived products.
    Type: Application
    Filed: March 20, 2024
    Publication date: September 26, 2024
    Inventors: Hiroshi Maeda, Yuri Takeda-Kimura, Bethany Moore
  • SERUM PROTEIN BIOMARKER PANEL FOR IDIOPATHIC PULMONARY FIBROSIS
    Publication number: 20240103017
    Abstract: The instant disclosure relates to methods for assessing pulmonary fibrosis disorder disease status in an individual in need thereof. One aspect of the disclosed methods may comprise: detecting a level of one or more biomarkers in a biological sample obtained from an individual, comparing the level of the one or more biomarkers to that of a control value corresponding to the one or more biomarkers, characterizing the disease status in the individual based on the level of the one or more biomarkers as compared to that of a relevant control value; and administering a treatment to said individual based on the assessment of the one or more biomarker levels.
    Type: Application
    Filed: October 8, 2020
    Publication date: March 28, 2024
    Inventors: William D. Hardie, Assem Ziady, Bethany Moore
  • OSTEOINDUCTIVE SUBSTRATES AND METHODS OF MAKING THE SAME
    Publication number: 20160082156
    Abstract: Systems and methods for preparing osteoinductive synthetic bone grafts are provided in which a porous ceramic granule is loaded with an osteoinductive material, and then placed in contact with a biocompatible matrix material.
    Type: Application
    Filed: August 28, 2015
    Publication date: March 24, 2016
    Inventors: Christopher G. WILSON, Eric J. Vanderploeg, Howard Seeherman, Zachary Decker, Eric Schmidt, Bethany Moore, Alexander Heubeck